foxo4-dri senolytic human trial peptide trials Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging Buy FOXO4-DRI (Proxofim) FOXO4-DRI: Human Trial Status, Cancer
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22

























